Abstract

Epithelial cell adhesion molecule EpCAM is expressed in pluripotent embryonic stem cells (ESC) in vitro, but is repressed in differentiated cells, except epithelia and carcinomas. Molecular functions of EpCAM, possibly imposing such repression, were primarily studied in malignant cells and might not apply to non-pathologic differentiation. Here, we comprehensively describe timing and rationale for EpCAM regulation in early murine gastrulation and ESC differentiation using single cell RNA-sequencing datasets, in vivo and in vitro models including CRISPR-Cas9-engineered ESC-mutants. We demonstrate expression of EpCAM in inner cell mass, epiblast, primitive/visceral endoderm, and strict repression in the most primitive, nascent Flk1+ mesoderm progenitors at E7.0. Selective expression of EpCAM was confirmed at mid-gestation and perinatal stages. The rationale for strict patterning was studied in ESC differentiation. Gain/loss-of-function demonstrated supportive functions of EpCAM in achieving full pluripotency and guided endodermal differentiation, but repressive functions in mesodermal differentiation as exemplified with cardiomyocyte formation. We further identified embryonic Ras (ERas) as novel EpCAM interactor of EpCAM and an EpCAM/ERas/AKT axis that is instrumental in differentiation regulation. Hence, spatiotemporal patterning of EpCAM at the onset of gastrulation, resulting in early segregation of interdependent EpCAM+ endodermal and EpCAM−/vimentin+ mesodermal clusters represents a novel regulatory feature during ESC differentiation.

Highlights

  • Epithelial cell adhesion molecule EpCAM was originally described as a cell surface antigen highly expressed in human carcinomas[1]

  • EpCAM mRNA expression was highest in cells of the inner cell mass (ICM) that comprises embryonic stem cells (ESC), was slightly reduced but remaining high in the epiblast at E4.5, E5.5 and E6.5, and was sustained at high levels throughout early endodermal differentiation, including primitive endoderm (E4.5), and various stages of visceral endoderm (E6.5–6.75), and in the primitive streak (Fig. 1a)

  • Throughout blastocyst and initiating gastrulation stages (E3.5–6.5), EpCAM was retained at high levels in cells of the inner cell mass, primitive and visceral endoderm, epiblast, and primitive streak

Read more

Summary

Introduction

Epithelial cell adhesion molecule EpCAM was originally described as a cell surface antigen highly expressed in human carcinomas[1]. Other fully differentiated cell types entirely lack expression of EpCAM. This selective expression implies substantial dynamics and tight control of EpCAM throughout differentiation of ESC into specified cell types Relief from this tight regulation are known from malignant transformation, where EpCAM is de novo expressed or up-regulated in carcinomas[10,11,12]. EpEX/EpCAM is, together with Oct3/4 or KLF4, sufficient to generate induced pluripotent stem cells in the human system[22]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call